Eumentis Therapeutics Inc is a cutting-edge biopharmaceutical company based in Newton Center, MA, dedicated to improving the lives of individuals with serious neuropsychiatric conditions. By integrating clinically validated science and advanced technology, they develop novel therapies that target the dysregulation of key neurotransmitters in the brain, such as dopamine and glutamate, to restore neural equilibrium.
With a mission to create and test urgently needed therapies, Eumentis Therapeutics applies a 21st-century understanding of brain science, collaborating with experts and family organizations to address the challenges faced by patients and their families. Their focus lies on pediatric neuropsychiatric conditions with limited treatment options, aiming to develop medications that effectively reduce symptoms without causing unwanted side effects.
Generated from the website